188 related articles for article (PubMed ID: 33248399)
21. Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer.
Shang AQ; Wu J; Bi F; Zhang YJ; Xu LR; Li LL; Chen FF; Wang WW; Zhu JJ; Liu YY
Cancer Biol Ther; 2017 May; 18(5):314-322. PubMed ID: 28448787
[TBL] [Abstract][Full Text] [Related]
22. The identification of a common different gene expression signature in patients with colorectal cancer.
Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
[TBL] [Abstract][Full Text] [Related]
23. Gene and protein expression profiles of JAK-STAT signalling pathway in the developing brain of the Ts1Cje down syndrome mouse model.
Lee HC; Md Yusof HH; Leong MP; Zainal Abidin S; Seth EA; Hewitt CA; Vidyadaran S; Nordin N; Scott HS; Cheah PS; Ling KH
Int J Neurosci; 2019 Sep; 129(9):871-881. PubMed ID: 30775947
[No Abstract] [Full Text] [Related]
24. JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer.
Bagratuni T; Mavrianou N; Gavalas NG; Tzannis K; Arapinis C; Liontos M; Christodoulou MI; Thomakos N; Haidopoulos D; Rodolakis A; Kastritis E; Scorilas A; Dimopoulos MA; Bamias A
Eur J Cancer; 2020 Feb; 126():125-135. PubMed ID: 31927213
[TBL] [Abstract][Full Text] [Related]
25. A novel potential target of IL-35-regulated JAK/STAT signaling pathway in lupus nephritis.
Cai Z; Zhang S; Wu P; Ren Q; Wei P; Hong M; Feng Y; Wong CK; Tang H; Zeng H
Clin Transl Med; 2021 Feb; 11(2):e309. PubMed ID: 33634995
[TBL] [Abstract][Full Text] [Related]
26. JAK and STAT members in channel catfish: Identification, phylogenetic analysis and expression profiling after Edwardsiella ictaluri infection.
Jin Y; Zhou T; Li N; Liu S; Xu X; Pan Y; Tan S; Shi H; Yang Y; Yuan Z; Wang W; Luo J; Gao D; Dunham R; Liu Z
Dev Comp Immunol; 2018 Apr; 81():334-341. PubMed ID: 29274790
[TBL] [Abstract][Full Text] [Related]
27. The Polyhomeotic protein induces hyperplastic tissue overgrowth through the activation of the JAK/STAT pathway.
González I; Simón R; Busturia A
Cell Cycle; 2009 Dec; 8(24):4103-11. PubMed ID: 19923887
[TBL] [Abstract][Full Text] [Related]
28. Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition.
Groner B; von Manstein V
Mol Cell Endocrinol; 2017 Aug; 451():1-14. PubMed ID: 28576744
[TBL] [Abstract][Full Text] [Related]
29. Silibinin eliminates mitochondrial ROS and restores autophagy through IL6ST/JAK2/STAT3 signaling pathway to protect cardiomyocytes from doxorubicin-induced injury.
Li W; Qu X; Kang X; Zhang H; Zhang X; Hu H; Yao L; Zhang L; Zheng J; Zheng Y; Zhang J; Xu Y
Eur J Pharmacol; 2022 Aug; 929():175153. PubMed ID: 35839932
[TBL] [Abstract][Full Text] [Related]
30. Genetic variants in IL-6/JAK/STAT3 pathway and the risk of CRC.
Wang S; Zhang W
Tumour Biol; 2016 May; 37(5):6561-9. PubMed ID: 26638167
[TBL] [Abstract][Full Text] [Related]
31. Association between the methylation of CpG islands in JAK-STAT pathway-related genes and colorectal cancer.
Rong J; Pu R; Sun H; Liu Y; Tian T; Bi H; Xia T; Zhang L; Zhang Y; Zhao Y; Zhu L
Gene; 2023 Jun; 868():147357. PubMed ID: 36914143
[TBL] [Abstract][Full Text] [Related]
32. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
[TBL] [Abstract][Full Text] [Related]
33. Activating mutations of the gp130/JAK/STAT pathway in human diseases.
Lokau J; Garbers C
Adv Protein Chem Struct Biol; 2019; 116():283-309. PubMed ID: 31036294
[TBL] [Abstract][Full Text] [Related]
34. Porphyromonas gingivalis Inhibition of MicroRNA-205-5p Expression Modulates Proinflammatory Cytokines in Gingival Epithelial Cells.
Li J; Li L; Wang X; Xiao L
Biochem Genet; 2020 Aug; 58(4):566-579. PubMed ID: 32303947
[TBL] [Abstract][Full Text] [Related]
35. LncRNA-135528 inhibits tumor progression by up-regulating CXCL10 through the JAK/STAT pathway.
Wang P; Peng X; Zhang J; Wang Z; Meng J; Cen B; Ji A; He S
Apoptosis; 2018 Dec; 23(11-12):651-666. PubMed ID: 30232656
[TBL] [Abstract][Full Text] [Related]
36. AZD1480, a JAK inhibitor, inhibits cell growth and survival of colorectal cancer via modulating the JAK2/STAT3 signaling pathway.
Wang SW; Hu J; Guo QH; Zhao Y; Cheng JJ; Zhang DS; Fei Q; Li J; Sun YM
Oncol Rep; 2014 Nov; 32(5):1991-8. PubMed ID: 25216185
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-induced MIF induces dysregulation of lipid metabolism in Hep2 laryngocarcinoma through the IL-6/JAK-STAT pathway.
Yang M; Wu S; Cai W; Ming X; Zhou Y; Chen X
Lipids Health Dis; 2022 Aug; 21(1):82. PubMed ID: 36042480
[TBL] [Abstract][Full Text] [Related]
38. KRT18 is correlated with the malignant status and acts as an oncogene in colorectal cancer.
Zhang J; Hu S; Li Y
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31345960
[TBL] [Abstract][Full Text] [Related]
39. An immunoevasive strategy through clinically-relevant pan-cancer genomic and transcriptomic alterations of JAK-STAT signaling components.
Chang WH; Lai AG
Mol Med; 2019 Nov; 25(1):46. PubMed ID: 31684858
[TBL] [Abstract][Full Text] [Related]
40. Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph).
Butterbach K; Beckmann L; de Sanjosé S; Benavente Y; Becker N; Foretova L; Maynadie M; Cocco P; Staines A; Boffetta P; Brennan P; Nieters A
Br J Haematol; 2011 May; 153(3):318-33. PubMed ID: 21418178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
